We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$54.7B
AUM Growth
+$1.45B
Cap. Flow
+$1.02B
Cap. Flow %
1.86%
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$65.3M
2
GPN icon
Global Payments
GPN
+$40.3M
3
MSFT icon
Microsoft
MSFT
+$37.9M
4
LHX icon
L3Harris
LHX
+$32.8M
5
AMZN icon
Amazon
AMZN
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 18.64%
2 Financials 15.56%
3 Healthcare 12.85%
4 Consumer Discretionary 10.31%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KDNY
2901
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$91K ﹤0.01%
17,178
+305
+2% +$2.02K
LITS
2902
Lite Strategy Inc
LITS
$32.1M
$87K ﹤0.01%
2,580
-32
-1% -$1.17K
ICD
2903
DELISTED
Independence Contract Drilling, Inc.
ICD
$87K ﹤0.01%
3,640
+320
+10% +$8.24K
RMNI icon
2904
Rimini Street
RMNI
$459M
$83K ﹤0.01%
18,925
-200
-1% -$974
JNCE
2905
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$83K ﹤0.01%
25,029
+2,094
+9% +$8.38K
VHI icon
2906
Valhi
VHI
$388M
$81K ﹤0.01%
3,534
+370
+12% +$9.45K
ASAP
2907
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$81K ﹤0.01%
3,165
+354
+13% +$22.7K
LVO icon
2908
LiveOne
LVO
$59.9M
$74K ﹤0.01%
3,672
+48
+1% +$1.23K
KZR
2909
DELISTED
Kezar Life Sciences
KZR
$72K ﹤0.01%
2,193
+186
+9% +$8.98K
LKSD
2910
DELISTED
LSC Communications, Inc.
LKSD
$72K ﹤0.01%
52,201
-49,035
-48% -$90.9K
XELA
2911
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$71K ﹤0.01%
5
ASNA
2912
DELISTED
Ascena Retail Group, Inc.
ASNA
$71K ﹤0.01%
13,467
-15,759
-54% -$117K
MRSN
2913
DELISTED
Mersana Therapeutics
MRSN
$69K ﹤0.01%
1,756
+177
+11% +$12.9K
PTE
2914
DELISTED
PolarityTE, Inc. Common Stock
PTE
$67K ﹤0.01%
829
+109
+15% +$12.5K
RTW
2915
DELISTED
RTW Retailwinds, Inc.
RTW
$67K ﹤0.01%
48,831
+4,272
+10% +$6.68K
ACRS icon
2916
Aclaris Therapeutics
ACRS
$835M
$58K ﹤0.01%
54,059
+4,164
+8% +$5.91K
IDEX
2917
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$58K ﹤0.01%
306
+5
+2% +$1.14K
AVTX icon
2918
Avalo Therapeutics
AVTX
$980M
$57K ﹤0.01%
6
SYBX
2919
DELISTED
Synlogic
SYBX
$56K ﹤0.01%
1,625
+149
+10% +$10.8K
EVFM
2920
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$54K ﹤0.01%
715
+8
+1% +$614
BBCP icon
2921
Concrete Pumping Holdings
BBCP
$497M
$53K ﹤0.01%
+13,406
New +$56.6K
TUSK icon
2922
Mammoth Energy Services
TUSK
$137M
$53K ﹤0.01%
21,173
+1,793
+9% +$8.51K
JILL icon
2923
J. Jill
JILL
$287M
$51K ﹤0.01%
5,412
+515
+11% +$5.24K
NL icon
2924
NLI Holdings
NL
$286M
$50K ﹤0.01%
13,405
+1,265
+10% +$4.99K
RVLP
2925
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$49K ﹤0.01%
12,859
+982
+8% +$3.33K

Similar funds

RhumbLine Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
  • RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
  • RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
  • RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
  • RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.

Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.